Laura G. Eichorn
Founder presso IMAGO BIOSCIENCES, INC.
Profilo
Laura G.
Eichorn is the founder and currently serves as the Chief Financial Officer at Imago BioSciences, Inc., a company she founded in 2012.
She previously worked as the Vice President-Operations & Finance at FerroKin BioSciences, Inc. Ms. Eichorn obtained her undergraduate degree from Frostburg State University.
Posizioni attive di Laura G. Eichorn
Società | Posizione | Inizio |
---|---|---|
IMAGO BIOSCIENCES, INC. | Founder | 01/03/2012 |
Precedenti posizioni note di Laura G. Eichorn
Società | Posizione | Fine |
---|---|---|
FerroKin BioSciences, Inc.
FerroKin BioSciences, Inc. Pharmaceuticals: MajorHealth Technology FerroKin BioSciences, Inc. offers clinical stage biotechnology services for iron chelator in the treatment of iron-overload in patients with transfusion-dependent hereditary and acquired refractory anemia. The company was founded by Hugh Young Rienhoff, Jr. in 2007 and is headquartered in San Carlos, CA. | Director of Finance/CFO | - |
Formazione di Laura G. Eichorn
Frostburg State University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
FerroKin BioSciences, Inc.
FerroKin BioSciences, Inc. Pharmaceuticals: MajorHealth Technology FerroKin BioSciences, Inc. offers clinical stage biotechnology services for iron chelator in the treatment of iron-overload in patients with transfusion-dependent hereditary and acquired refractory anemia. The company was founded by Hugh Young Rienhoff, Jr. in 2007 and is headquartered in San Carlos, CA. | Health Technology |
Imago BioSciences, Inc.
Imago BioSciences, Inc. BiotechnologyHealth Technology Imago BioSciences, Inc. operates as a clinical-stage biopharmaceutical company that develops novel anti-cancer therapeutics. It translates science of genetics and epigenetics enzymes into novel medicines for treating myeloid diseases that pose challenges to patients, families, and physicians. The company also translates insights into transformative therapies that alter the history of disease allowing patients to live longer and disease-free lives. Imago BioSciences was founded by Hugh Young Rienhoff, Jr., Laura G. Eichorn and Jennifer Peppe on March 29, 2012 and is headquartered in Redwood City, CA. | Health Technology |
- Borsa valori
- Insiders
- Laura G. Eichorn